Bausch + Lomb Corp. (BLCO) shares surged 13.88% in pre-market trading on Wednesday following the release of its third-quarter earnings report, which exceeded analyst expectations. The eyecare company's strong performance and maintained guidance have bolstered investor confidence, driving the significant stock price increase.

The company reported adjusted earnings per share of $0.18 for Q3, surpassing the analyst consensus estimate of $0.16 by 12.5%. This represents a notable improvement from $0.13 per share in the same quarter last year. Revenue for the quarter came in at $1.28 billion, meeting Wall Street's expectations and marking a 7.1% increase year-over-year.

Notably, Bausch + Lomb maintained its full-year 2025 revenue guidance of $5.05 billion to $5.15 billion, instilling confidence in the company's growth trajectory. The reaffirmed guidance, coupled with the earnings beat, suggests that the company is successfully navigating market challenges and executing its strategic initiatives.

Brent Saunders, chairman and CEO of Bausch + Lomb, commented on the results, stating, "We're delivering on the vision we laid out in 2023, with a base business engine that continues to hum and steady introduction of innovative products across categories." This positive outlook from management has further fueled investor optimism, contributing to the stock's pre-market rally.

The market's enthusiastic response to Bausch + Lomb's earnings report underscores the importance of strong financial performance and clear growth prospects in driving stock valuations. As trading opens on Wednesday, investors will be closely watching to see if the pre-market gains hold and whether analyst upgrades follow this impressive quarterly showing.